期刊文献+

血清脂蛋白相关磷脂酶A2水平与冠状动脉粥样硬化性病变的关系 被引量:14

Relationship of serum lipoprotein-associated phospholipase A2 and coronary atherosclerosis
原文传递
导出
摘要 目的探讨血清脂蛋白相关磷脂酶A2(Lp-PLA2)水平与冠状动脉(冠脉)粥样硬化性病变的关系。方法行冠脉造影患者327例,224例诊断为冠心病(CHD组),103例无CHD作为对照组。检测并分析血清Lp-PLA2水平与CHD病变的关系。结果 CHD组Lp-PLA2水平高于对照组[(134.74±45.67)ng/ml vs.(114.38±45.80)ng/ml](P〈0.01)。经调整年龄、糖尿病、HDL-C和收缩压等因素,Lp-PLA2水平与CHD密切相关(OR=1.262,95%CI:1.160-1.610,P〈0.05)。CHD组Lp-PLA2水平与冠脉病变支数和Gensini积分呈正相关(r=0.190和0.222,P〈0.01)。结论血清Lp-PLA2水平是CHD的独立危险因素,可提示冠脉病变的血管狭窄程度,但与病变稳定性无密切相关。 Objective To investigate the relationship of serum lipoprotein-associated phospholipase A2(Lp-PLA2)and the lessions of coronary arterial atherosclerosis.Methods Coronary angiography was performed in 327 consecutive patients,of whom 158 cases were diagnosed as coronary heart disease(group CHD)and 103 cases were not as the controls(group C).Serum levels of Lp-PLA2 were measured and the relationship of serum Lp-PLA2 and the lessions of coronary arterial atherosclerosis was analyzed.Results Serum level of Lp-PLA2 in group CHD was higher than that in group C[(134.74±45.67)ng/ml vs.(114.38±45.80)ng/ml](P〈0.01).After adjusted for age,blood pressure,diabetes and high density lipoprotein cholesterol,serum level of Lp-PLA2 was correlated with CHD(OR=1.262,95%CI:1.160-1.610,P〈0.05).The level of Lp-PLA2 was positively correlated with the number of diseased coronary branches and Gensinis scores(r=0.190 and 0.222,P〈0.01).Conclusion Serum Lp-PLA2 is an independent risk factor for CHD,which may indicate the severity of coronary arterial atherosclerosis,but is not closely related to the stability of the lesions.
出处 《江苏医药》 CAS 2016年第7期764-767,共4页 Jiangsu Medical Journal
基金 国家自然科学基金(81370225)
关键词 脂蛋白相关磷脂酶A2 冠心病 Lipoprotein-associated phospholipase A2 Coronary heart disease
  • 相关文献

参考文献10

  • 1Tuttolomondo A,Di Raimondo D,Pecoraro R,et al.Atherosclerosis as an inflammatory disease[J].Curr Pharm Des,2012,18(28):4266-4288.
  • 2Oei HH,van der Meer IM,Hofman A,et al.Lipoproteinassociated phospholipase A2activity is associated with risk of coronary heart disease and ischemic stroke:the Rotterdam Study[J].Circulation,2005,111(5):570-575.
  • 3Daniels LB,Laughlin GA,Sarno MJ,et al.Lipoproteinassociated phospholipase A2is an independent predictor of incident coronary heart disease in an apparently healthy older population:the Rancho Bernardo Study[J].J Am Coll Cardiol,2008,51(9):913-919.
  • 4Gensini GG.A more meaningful scoring system for determining the severity of coronary heart disease[J].Am JCardiol,1983,51(3):606.
  • 5Kolodgie FD,Burke AP,Skorija KS,et al.Lipoproteinassociated phospholipase A2protein expression in the natural progression of human coronary atherosclerosis[J].Arterioscler Thromb Vasc Biol,2006,26(11):2523-2529.
  • 6Kakkos SK,Tsolakis IA.The emerging role of lipoproteinassociated phospholipase A2in cerebrovascular disease[J].Eur J Vasc Endovasc Surg,2012,43(2):160.
  • 7Winkler K.,Winkelmann B.R.,Scharnagl H.,刘文秀.血小板活化因子乙酰水解酶活性可独立于全身炎症和其他危险因素提示血管造影阳性冠状动脉疾病:Ludwigshafen风险和心血管健康状况研究[J].世界核心医学期刊文摘(心脏病学分册),2005,0(8):34-35. 被引量:31
  • 8Brilakis ES,McConnell JP,Lennon RJ,et al.Association of lipoprotein-associated phospholipaseA2levels with coronary artery disease risk factors,angiographic coronary artery disease,andmajor adverse events at follow-up[J].Eur Heart J,2005,26(2):137-144.
  • 9焦云根,刘乃丰,孙晓宁,张振刚.急性冠状动脉综合征患者血清sLox-1和hsCRP检测的意义[J].江苏医药,2014,40(20):2434-2437. 被引量:5
  • 10Takano M,Inami S,Ishibashi F,et al.Angioscopic follow-up study of coronary ruptured plaques in nonculprit lesions[J].JAm Coll Cardiol,2005,45(5):652-658.

二级参考文献14

  • 1Halvorsen B, Otterdal K, Dahl TB, et al. Atherosclerotie plaque stabilitywhat dertermines the fate of a plaque[J]? Prog Cardiovasc Dis,2008,51(3):183-194.
  • 2Dunn S, Vohra RS, Murphy JE, et al. The lectin-like oxidized low-density-lipoprotein receptor: a pro-inflammatory factor in vascular disease[J]. Biochem J, 2008,409 (2) : 349-355.
  • 3Sawamura T, Kume N, Aoyama T, et al. An endothelial receptor for oxidized low-density lipoprotein [J]. Nature, 1997,386 (6620) : 73-77.
  • 4Navarra T, Del Turco S, Berti S, et al. The lectin-like oxidized low-density lipoprotein receptor-1 and its soluble form: cardiovascular implications[J]. J Atheroscler Thromb, 2010, 17(4) :317-331.
  • 5Nakano A, Inoue N, Sato Y, et al. Lox-1 mediates vascular lipid retention under hypertensive state [J]. J Hypertens, 2010,28(6) : 1273-1280.
  • 6Ishino S, Mukai T, Kuge Y, etal. Targeting of lectinlike oxidized low-density lipoprotein receptor 1 (LOX-1) with 99roTe-labeled anti-LOX-1 antibody: potential agent for imaging of vulnerable plaque[J]. J Nucl Med, 2008,49 (10): 1677-1685.
  • 7Li D, Patel AR, Klibanov AL, et al. Molecular imaging of atherosclerotie plaques targeted to oxidized LDL receptor Lox-1 using SPECT/CT and magnetic resonance[J]. Cire Cardiovasc Imaging, 2010,3 (4) : 464-472.
  • 8Hayashida K,Kume N,Murase T,et al. Serum soluble lectin- like oxidized lovc-derLsity lipoprotein receptor-1 levels are elevated in acute coronary syndrome., a novel marker for early diagnosis[J]. Circulation, 2005,112 (6) : 812-818.
  • 9KumeN, Mitsuoka H, Hayashida K, et al. Soluble leetin-likeoxidized LDL reeeptor-l(sLOX-1) as a sensitive and specific biomarker for acute coronary with other biomarkers[J]. J Cardiol, 2010,56 (2) : 159-165.
  • 10Moreno PtL Pathophysiology of plaque disruption and throm- bosis in acute ischemic syndromes[J]. J Stroke Cerebrovase Dis,2001,10(2 Pt 2) :2-9.

共引文献34

同被引文献82

引证文献14

二级引证文献49

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部